Cimetidine pharmacokinetics and dosage requirements in children
- PMID: 4018106
- DOI: 10.1007/BF00491931
Cimetidine pharmacokinetics and dosage requirements in children
Abstract
The pharmacokinetics of cimetidine (10 mg/kg) were investigated in 11 children following an oral dose and in 9 children following an intravenous dose. The children ranged in age from 4-13 years and were undergoing radiology for upper gastrointestinal tract pain. Compared with a group of adults, the children had a higher total body clearance (11.6 +/- 3.4 versus 7.0 +/- 2.5 ml/min per kg; P less than 0.005), a larger apparent volume of distribution (1.24 +/- 0.40 versus 0.80 +/- 0.24 l/kg; P less than 0.005) and a shorter elimination half-life (83 +/- 26 versus 122 +/- 16 min; P less than 0.001) of cimetidine. Renal clearance in children comprised 70% of total body clearance, more than double that of adults (9.0 +/- 1.9 versus 4.2 +/- 2.1 ml/min per kg; P less than 0.001). The area under the cimetidine plasma concentration: time curve after the oral dose was on average 42% in children compared with adults. The mechanism for the increased elimination of cimetidine in children is suggested to be an increase in the renal tubular secretory transport of cimetidine in the kidney. A statistically significant negative correlation was observed between age and cimetidine renal clearance. A cimetidine dosage regimen of approximately 30 mg/kg per day in three to four divided doses would be an appropriate dose in children.
Similar articles
-
Dosage regimen of cimetidine reviewed. Possible drug accumulation after multiple oral doses.Eur J Clin Pharmacol. 1988;34(6):539-42. doi: 10.1007/BF00615214. Eur J Clin Pharmacol. 1988. PMID: 3049117 Review.
-
Pharmacokinetics of cimetidine in critically ill children.Pediatr Pharmacol (New York). 1982;2(4):285-92. Pediatr Pharmacol (New York). 1982. PMID: 6927127
-
The bioavailability and pharmacokinetics of cimetidine and its metabolites in juvenile cystic fibrosis patients: age related differences as compared to adults.Eur J Clin Pharmacol. 1984;26(2):183-9. doi: 10.1007/BF00630284. Eur J Clin Pharmacol. 1984. PMID: 6723756
-
Prediction of cimetidine disposition in the aged.Methods Find Exp Clin Pharmacol. 1983;5(4):255-62. Methods Find Exp Clin Pharmacol. 1983. PMID: 6888088
-
Clinical pharmacokinetics of cimetidine.Clin Pharmacokinet. 1983 Nov-Dec;8(6):463-95. doi: 10.2165/00003088-198308060-00001. Clin Pharmacokinet. 1983. PMID: 6418428 Review.
Cited by
-
Dosage regimen of cimetidine reviewed. Possible drug accumulation after multiple oral doses.Eur J Clin Pharmacol. 1988;34(6):539-42. doi: 10.1007/BF00615214. Eur J Clin Pharmacol. 1988. PMID: 3049117 Review.
-
Alteration by burn injury of the pharmacokinetics and pharmacodynamics of cimetidine in children.Eur J Clin Pharmacol. 1989;36(4):361-7. doi: 10.1007/BF00558296. Eur J Clin Pharmacol. 1989. PMID: 2737228
-
Development of Human Membrane Transporters: Drug Disposition and Pharmacogenetics.Clin Pharmacokinet. 2016 May;55(5):507-24. doi: 10.1007/s40262-015-0328-5. Clin Pharmacokinet. 2016. PMID: 26410689 Free PMC article. Review.
-
Paediatric pharmacokinetics: key considerations.Br J Clin Pharmacol. 2015 Mar;79(3):395-404. doi: 10.1111/bcp.12267. Br J Clin Pharmacol. 2015. PMID: 25855821 Free PMC article. Review.
-
Factors and Mechanisms for Pharmacokinetic Differences between Pediatric Population and Adults.Pharmaceutics. 2011 Feb 7;3(1):53-72. doi: 10.3390/pharmaceutics3010053. Pharmaceutics. 2011. PMID: 24310425 Free PMC article.